A comprehensive multiplex PCR panel for rapid detection of bacterial, viral, fungal, and antimicrobial resistance (AMR) gene targets directly from cerebrospinal fluid (CSF). Enables timely identification of CNS pathogens in meningitis and encephalitis — critical for early targeted therapy and improved patient outcomes.
Meningitis and encephalitis are life-threatening infections of the central nervous system (CNS) requiring immediate diagnostic workup and empiric antimicrobial treatment. Identifying the causative pathogen rapidly is critical to guide de-escalation from empiric broad-spectrum therapy.
Traditional CSF culture and serology methods are slow and have limited sensitivity. The Genplex™ Meningitis/Encephalitis Panel uses multiplex PCR technology to simultaneously detect bacterial, viral, and fungal pathogens along with AMR resistance genes directly from CSF — in a fraction of the time.
The panel covers 8 bacterial targets (including MTB, NTM), 7 viral targets (CMV, HSV-1, HSV-2, Enterovirus, VZV, etc.), 1 fungal target (Cryptococcus), and AMR resistance genes — giving clinicians a comprehensive CNS infection profile.
Advanced molecular diagnostic capabilities engineered for clinical excellence and research-grade precision.
Delivers CNS pathogen identification in hours — enabling faster targeted therapy decisions vs. traditional culture.
Superior sensitivity in detecting pathogens directly from CSF, even at low pathogen loads.
Simultaneously detects bacterial, viral, fungal pathogens, and AMR genes from a single CSF specimen.
Identifies key resistance genes to guide empiric antibiotic de-escalation and targeted therapy.
Targets selected based on clinical prevalence and relevance in bacterial and viral CNS infections.
No culture required — results directly from CSF without pre-enrichment or prolonged incubation.
Comprehensive multiplex detection covering a broad spectrum of clinically relevant pathogens and resistance markers.
Designed for diverse diagnostic and research use cases across the clinical spectrum.
Rapid identification of bacterial CNS pathogens for early targeted antibiotic therapy.
Detection of neurotropic viruses including HSV-1/2, CMV, Enterovirus, and VZV from CSF.
Detection of Cryptococcus neoformans/gattii in immunocompromised patients.
AMR gene detection enables rapid de-escalation from broad-spectrum empiric therapy.
| Parameter | Value / Description |
|---|---|
| Sample Type | Cerebrospinal Fluid (CSF) |
| Bacterial Targets | 8 (including MTB & NTM) |
| Viral Targets | 7 (CMV, HSV-1, HSV-2, Enterovirus, VZV, Parvovirus B19, Parechovirus) |
| Fungal Targets | 1 (Cryptococcus neoformans/gattii) |
| AMR Genes | Included |
| Detection Method | Qualitative Multiplex PCR |
| Intended Use | In Vitro Diagnostic (IVD) |
| Storage | -20°C |
For in vitro diagnostic use. Contact your regional distributor or ProbGen representative to place an order.
| Product Name | Cat. No. | Pack Size |
|---|---|---|
| Genplex™ Meningitis / Encephalitis Panel | GP1058 | 48 tests |
| Genplex™ Meningitis / Encephalitis Panel | GP1059 | 96 tests |
Contact our scientific team for technical specifications, bulk pricing, or to request a demonstration of our diagnostics solutions.
Contact Us All Products